Ellen Chiniara Kymera Therapeutics, Inc. (KYMR) insider trading activity

KYMR Quotes by TradingView

Ellen Chiniara is Chief Legal Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 54,826 shares of KYMR, which is worth approximately $2.16 Million. The most recent transaction as insider was on Jan 06, 2025, when has been sold 3,129 shares (Common Stock) at a price of $41.75 per share, resulting in proceeds of $130,635. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 54.8K
2.03% 3M change
60.29% 12M change
Total Value Held $2.16 Million

Ellen Chiniara Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2025
SELL
Open market or private sale
$130,635 $41.75 p/Share
3,129 Reduced 5.4%
54,826 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
21,755 Added 27.99%
55,960 Common Stock
Jan 04 2024
SELL
Open market or private sale
$74,401 $22.58 p/Share
3,295 Reduced 8.79%
34,205 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
37,500 Added 50.0%
37,500 Common Stock

Also insider at

ALXN
ALEXION PHARMACEUTICALS, INC.
EVP & Chief Legal Officer
CMPX
Compass Therapeutics, Inc. Healthcare
Director
EC

Ellen Chiniara

Chief Legal Officer
Boston, MA

Track Institutional and Insider Activities on KYMR

Follow Kymera Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

News

Receive news related to Kymera Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KYMR